The PKA L205R hotspot mutation has been implicated in Cushing's Syndrome through 2 hyperactive gain-of-function PKA signaling, however its influence on substrate 3 specificity has not been investigated. Here, we employ the Proteomic Peptide Library 4 (ProPeL) approach to create high-resolution models for PKA WT and PKA L205R substrate 5 specificity. We reveal that the L205R mutation reduces canonical hydrophobic preference 6 at the substrate P+1 position, and increases acidic preference in downstream positions.
Introduction 21
Cushing's Syndrome is defined by a collection of signs and symptoms that result from 
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which allowed for differential serine, threonine, and tyrosine phosphate modifications 106 (+79.966331), a differential methionine oxidation modification (15.9949146221) and a constant 107 cysteine modification of +57.02146374. The deltaXCORR (the difference between the first and 108 second hits to the databases) was set to be >= 0.08. To minimize false positives, for each of the 109 two classes of peptide charges z = +2 and z >= +3, XCORR thresholds were chosen to accept 110 peptides in such a manner that 1% of them were hits from the decoy database, resulting in an Table S1 ). for downstream acidic residues in the motif may be due to an electrostatic interaction with a 195 positively charged R205 guanidinium group in the mutant kinase. Conversely, we note that the 196 canonical basophilic preference at substrate positions P-2 and P-3 by PKA WT was unaltered for 197 PKA L205R , which is consistent with conserved interactions with PKI in the mutant crystal structure 198 ( Fig. S1 ). PKA L205R motifs for substrates that contain threonine P-sites are largely similar to the 199 serine motifs, although there appears to be an even greater shift away from hydrophobic P+1 200 preference and a less pronounced increase in acidic enrichment at downstream positions 201 ( Fig. S3 ). Together, these results demonstrate that the Cushing's syndrome mutant PKA L205R 202 does indeed alter PKA substrate specificity, and in a manner predicted by the existing crystal 203 structure data. The processed ProPeL experimental data are provided in Table S2 . Interested 204 readers may follow the detailed instructions for re-creating these pLogos to dynamically explore 205 the correlated positions within the motifs (see Supporting Information). 
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Observed Peptide 2 -IVLPRRLSDEVADRV). As a benchmark, we also selected a known 215 human PKA WT substrate for synthesis (CDK16 S119 -EDINKRLSLPADIRL [24]). The in vitro 216 kinase assay revealed that both the observed E. coli peptides and the human CDK16 S119 217 peptide were readily phosphorylated (Fig. 3A) , and a one-way ANOVA found that the means are 218 not significantly different [F(2,14) = 0.56, p = 0.58349], verifying that phosphorylation sites 219 obtained through ProPeL E. coli experiments are a suitable proxy for real human substrates.
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Next, we validated the observed specificity drift of the PKA L205R mutation. We designed 221 peptides based on the best residues at each position for each of the PKA WT and PKA L205R 222 pLogos (RKRRRRKSFIENDRR and KRRRRRGSLDEDDQG, respectively) to assess the 223 differential activity of each PKA variant for consensus substrates. While both peptides are viable 224 substrates for both PKA variants, it is clear when comparing phosphorylation levels that the 225 PKA WT pLogo-derived peptide is preferentially phosphorylated by PKA WT , while the PKA L205R 226 pLogo-derived peptide is preferentially phosphorylated by PKA L205R (Fig. 3B,C) . This provides 227 independent validation of the kinase specificity motifs identified by ProPeL using an orthogonal 228 approach.
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Having demonstrated that there is indeed a shift in substrate specificity, we sought to 230 use this information to guide the design of peptide substrates with altered kinase selectivity. The 231 gold-standard PKA consensus substrate Kemptide (LRRASLG) has been previously used to 232 evaluate not only PKA WT activity, but also PKA L205R activity [5]. As mentioned above, PKA WT 233 displays a general preference for all hydrophobic residues in the P+1 position, while PKA L205R 234 retains only leucine from this hydrophobic grouping. As Kemptide contains arginine residues in 235 the P-2 and P-3 positions and leucine at P+1, it conforms to our specificity models for both PKA 236 variants. We hypothesized that replacing the Kemptide P+1 leucine with a valine (i.e.
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LRRASVG) would reduce phosphorylation by PKA L205R , while maintaining high phosphorylation 238 levels by PKA WT . Indeed, our "Kemptide +1V" peptide exhibits increased selectivity towards 239 PKA WT over PKA L205R when compared with standard Kemptide (Fig. 3B,C) . Next, we 240 investigated the biologically relevant regulatory subunit RIα interaction site (RRGAI). We 241 hypothesized that by rationally mutating the RIα pseudo-substrate towards our model of 242 PKA L205R specificity, we could "rescue" the interaction between the Cushing's mutant kinase and 243 the RIα binding site. We synthesized an alanine-to-serine phosphoacceptor-substituted RIα 244 peptide "RIα (P 0 sub.)" to convert the interaction site to a potential substrate 245 (KGRRRRGSISAEVYT). Based on our PKA L205R ProPeL experimental findings, we also 246 synthesized a version of the peptide with the putative +1 and +2 residues mutated to aspartate 247 and glutamate, respectively, yielding an "RIα (acidic)" peptide (KGRRRRGSDEAEVYT). The 248 in vitro kinase assays revealed that RIα (P 0 sub.) is phosphorylated at a higher level by PKA WT , 249 and that RIα (acidic) is phosphorylated at a higher level by PKA L205R (Fig. 3B,C) .
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Finally, we wanted to test the feasibility of the hypothesis that the L205R mutation could 251 induce substrate rewiring. Using the internal version of scan-x, we scored all of the known 252 human PKA substrates (curated from the PhosphositePlus database [24]) with the PKA WT and 253 PKA L205R motifs, and determined CDK16 S119 as a candidate loss-of-function substrate for 254 PKA L205R . The in vitro kinase assay revealed that phosphorylation of the CDK16 S119 peptide by 12 PKA L205R was significantly reduced compared to PKA WT (Fig. 3D , n = 8 technical replicates, 256 t-test, p = 3.04 x 10 -6 ). This result demonstrates both the feasibility of PKA L205R loss-of-function 257 mutations, and that ProPeL-generated specificity models can be utilized for predicting kinase 258 substrate rewiring. (Fig. 3B,C, and Fig. S4 ). Both substrate selection and the absence of regulatory 278 inhibition are therefore critical when designing and interpreting the results of a kinase catalytic 279 activity assay. According to our model, many canonical substrates that conform to the PKA WT 280 13 [R/K][R/K]xSϕ motif would remain viable targets for PKA L205R , in agreement with recent 281 findings [4-7,11]. In fact, CREB S133 and ATF1 S63 have identical substrate sites containing 282 RRPSY, where we note that tyrosine is neither favored nor disfavored at the P+1 position.
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Because this peptide sequence matches favorably with both the PKA WT and PKA L205R motifs, 284 these substrates would actually be poor candidates to evaluate a change in PKA L205R specificity, 285 and may explain why prior studies might have missed the altered specificity that we observe. 
